IE46170B1 - Prostane derivatives - Google Patents

Prostane derivatives

Info

Publication number
IE46170B1
IE46170B1 IE2409/77A IE240977A IE46170B1 IE 46170 B1 IE46170 B1 IE 46170B1 IE 2409/77 A IE2409/77 A IE 2409/77A IE 240977 A IE240977 A IE 240977A IE 46170 B1 IE46170 B1 IE 46170B1
Authority
IE
Ireland
Prior art keywords
radical
alkyl
acid
cis
trans
Prior art date
Application number
IE2409/77A
Other languages
English (en)
Other versions
IE46170L (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IE46170L publication Critical patent/IE46170L/xx
Publication of IE46170B1 publication Critical patent/IE46170B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
IE2409/77A 1976-12-08 1977-11-28 Prostane derivatives IE46170B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51196/76A GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives

Publications (2)

Publication Number Publication Date
IE46170L IE46170L (en) 1978-06-08
IE46170B1 true IE46170B1 (en) 1983-03-09

Family

ID=10459023

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2409/77A IE46170B1 (en) 1976-12-08 1977-11-28 Prostane derivatives

Country Status (14)

Country Link
JP (1) JPS5371060A (enExample)
AU (1) AU3104477A (enExample)
BE (1) BE861652A (enExample)
CA (1) CA1119591A (enExample)
DE (1) DE2754741A1 (enExample)
DK (1) DK548177A (enExample)
FR (1) FR2373538A1 (enExample)
GB (1) GB1550399A (enExample)
IE (1) IE46170B1 (enExample)
IT (1) IT1089433B (enExample)
NL (1) NL7713587A (enExample)
NZ (1) NZ185822A (enExample)
SE (1) SE7713895L (enExample)
ZA (1) ZA777059B (enExample)

Also Published As

Publication number Publication date
AU3104477A (en) 1979-06-07
ZA777059B (en) 1978-08-30
FR2373538B1 (enExample) 1981-07-10
CA1119591A (en) 1982-03-09
JPS5371060A (en) 1978-06-24
BE861652A (fr) 1978-06-08
SE7713895L (sv) 1978-06-09
NL7713587A (nl) 1978-06-12
DK548177A (da) 1978-06-09
DE2754741A1 (de) 1978-06-15
IE46170L (en) 1978-06-08
FR2373538A1 (fr) 1978-07-07
NZ185822A (en) 1979-03-16
GB1550399A (en) 1979-08-15
IT1089433B (it) 1985-06-18

Similar Documents

Publication Publication Date Title
US3954881A (en) Prostanoic acid derivatives
CA1059122A (en) 2-descarboxy-2 (tetrazol-5-yl)-11-desoxy-15-substituted ?-pentanorprostaglandins
US4024179A (en) Substituted ω-pentanorprostaglandins
US3883513A (en) Tetrazoyl derivatives of naturally occurring prostaglandins
IE54097B1 (en) Azaprostacyclins, process for their manufacture and their pharmaceutical use
US3931206A (en) Prostanoic acid derivatives
EP0159784B1 (en) Carbacyclin analogues
US3953502A (en) Cyclopentane derivatives
US4004020A (en) Novel prostanoic acid derivatives and process for the preparation thereof
US3984424A (en) P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
CA1042002A (en) Cyclopentane derivatives
US4321275A (en) Method of inducing luteolysis using 16-aryloxy-17,18,19,20-tetranor-prostanoic acid derivatives
US4105854A (en) Prostanoic acid derivatives
US4000305A (en) 15-, 16- AND 17-Indolyl or indolinyl nor prostanoic acid derivatives
CA1067490A (en) Prostanoic acid derivatives
GB1572879A (en) 7-thiaprosta-glandins and derivatives thereof
IE46170B1 (en) Prostane derivatives
US4096337A (en) Prostane derivatives
US4241215A (en) Prostane derivatives
CA1212669A (en) Benzopyran compounds
US4004021A (en) Cyclopentane derivatives
US3953466A (en) 4(Tetrazol-5-yl)-butyltriphenylphosphonium halide compounds
US4115580A (en) 3,4-Epoxy-cyclopenta-1,2-diyl prostanes
US3952033A (en) Furan intermediates and process for synthesis of 4-hydroxycyclopetenones, prostaglandin synthesis intermediates
US4109015A (en) Prostane derivatives